A great activation with a delicious Beverage! NUTRL is available in your favorite fruit flavors from Orange, Black Cherry, and Pineapple, to Watermelon, and more!
We had an electric time at Ecostage! Non-stop music, good vibes, and delicious drinks by Nütrl kept the party going!! ⚡
Huge props to our amazing consumer educator Anna for bringing her A-Game and keeping everyone refreshed all night!
.
.
.
#mybrandbuilders#eventmarketing#AGame#dmv#vodka#nutrl#cocktails#drinks
Why Billboard Beverages is the Perfect Spot for Your Brand.
Did you know the average person holds a beer for 10-20 minutes while drinking? That’s 10-20 minutes where your brand is literally in their hand—on our mobile billboards (aka beer cans)! 🍻
With Billboard Beverages, you’re not just getting a quick glance; you’re creating a lasting impression in a fun, relaxed environment. Whether it’s at a party, concert, or just a casual get-together, your brand gets undivided attention during those crucial moments.
Why settle for a fleeting ad when your brand could be front and center for the entire drink?
#BillboardBevs#BrandInHand#MarketingInnovation#DrinkAndDiscover#AdInHand
Contract Canna and CQ have been steadily expanding the brand’s beverage line since launch. The latest addition, Iced Tea + Mango Lemonade, is a refreshing step beyond existing shots and sodas.
I recently stopped at Parkway Dispensary Tilton and picked up a can to review.
https://lnkd.in/gBMQwtKs
Music by News Joint Music Machine
Contract CannaCQ DrinksMichael Lasley
Anesthesiologist and intensive care physician at the IRCCS Besta neurocenter, Milano. Social Media Editor at the Journal of Clinical Monitoring and Computing.
There are two topics that greatly intrigue anesthesiologists on social media. One is the use of off-label drug cocktails in neuraxial anesthesia, and the other is drug mixes for TIVA. In both cases, these discussions are very popular among clinicians because they appeal to a nostalgic, pseudo-magical view of the profession.
There is no rational basis for proposing fixed mixes of intravenous drugs, which prevent titration of single drugs based on individual responses, possibly measured through objective endpoints. Period.
Let’s focus on real issues like the balance between hypertechnology and costs, or the major challenges posed by the use of large volumes of data in clinical practice. Not everything people talk about is worthy of attention, IMO.
Francisco A Lobo